Homepage
Open in app
Sign in
Get started
What is Due Diligence?
The (free) newsletter
Tagged in
Stock Market
Due Diligence
We analyze, compile, condense, and share our fundamental analysis of select companies in a concise and easy-to-digest format.
More information
Followers
72
More, on Medium
Stock Market
Carter Kilmann
in
Due Diligence
Jan 25, 2023
The National Defense Stockpile Is Low. Is That Good News for MP?
It’s a good time to be the only…
Read more…
Carter Kilmann
in
Due Diligence
Apr 1, 2022
Is Royal Gold Stock a Better Safe Haven During Recessions Than Real Gold?
Exploring the recent…
Read more…
2 responses
Carter Kilmann
in
Due Diligence
Feb 18, 2022
Is BOTZ the Best Robotics ETF? Here Are Reasons Why It Might Be
The due diligence of the BOTZ ETF and…
Read more…
51
Carter Kilmann
in
Due Diligence
Feb 11, 2022
2 Growth Stocks Moving in Opposite Directions: TDC and TDOC
Can Teradata stock surge back to its…
Read more…
Carter Kilmann
in
Due Diligence
Feb 4, 2022
When ARKK ETF Gets Absolutely Clobbered, SARK ETF Wins Big. Here’s Why
The due diligence of Tuttle…
Read more…
160
Carter Kilmann
in
Due Diligence
Jan 28, 2022
Market Movers: 6 Stocks That Blew Up Last Year — the Good and Bad Kind
Can the biggest stock gainers…
Read more…
157
Carter Kilmann
in
Due Diligence
Dec 10, 2021
3 Crazy Growth Stocks and 3 Stocks That Have Taken a Beating
Can Peloton get its second wind?
Read more…
4
Carter Kilmann
in
Due Diligence
Jul 16, 2021
Can Clover Health Overcome Its Status as a Meme Stock?
Why Clover Health became a meme stock and a…
Read more…
152
1 response
Carter Kilmann
in
Due Diligence
May 28, 2021
Is Cresco Labs the New King of Cannabis Stocks?
The fundamental analysis of Cresco Labs and its…
Read more…
188
Carter Kilmann
in
Due Diligence
May 14, 2021
Is Pfizer Really an Unexpected Gem or a Stock to Avoid?
The fundamental analysis of Pfizer and its…
Read more…
151